Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Sep 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$283,360
$46.1 P/Share
|
|
Sep 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Sep 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$301,840
$49.01 P/Share
|
|
Sep 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Sep 09
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.14%
|
$595,972
$52.59 P/Share
|
|
Sep 09
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.97%
|
$11,461
$1.64 P/Share
|
|
Sep 07
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.14%
|
$595,972
$52.5 P/Share
|
|
Sep 07
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.97%
|
$11,461
$1.64 P/Share
|
|
Sep 01
2021
|
Casdin Partners Master Fund, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
126,185
+1.64%
|
-
|
|
Aug 27
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
399
-0.19%
|
$22,743
$57.26 P/Share
|
|
Aug 26
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
848
-0.32%
|
$48,336
$57.26 P/Share
|
|
Aug 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
325
-0.45%
|
$18,525
$57.26 P/Share
|
|
Aug 25
2021
|
Joseph C Schick Director |
SELL
Open market or private sale
|
Direct |
1,875
-13.64%
|
$97,500
$52.54 P/Share
|
|
Aug 25
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.55%
|
$530,000
$53.12 P/Share
|
|
Aug 25
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Aug 23
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,332
-18.33%
|
$751,272
$46.54 P/Share
|
|
Aug 23
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,332
+15.49%
|
$16,332
$1.64 P/Share
|
|
Aug 23
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.55%
|
$460,000
$46.54 P/Share
|
|
Aug 23
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Aug 19
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
12,000
-8.53%
|
$540,000
$45.12 P/Share
|
|
Aug 18
2021
|
Joseph C Schick Director |
SELL
Open market or private sale
|
Direct |
625
-4.35%
|
$27,500
$44.11 P/Share
|
|
Aug 18
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
22,239
-7.08%
|
$978,516
$44.7 P/Share
|
|
Aug 17
2021
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
12,000
-6.86%
|
$528,000
$44.81 P/Share
|
|
Aug 17
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$271,040
$44.8 P/Share
|
|
Aug 17
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Aug 16
2021
|
Andrew G Hinson Director |
SELL
Open market or private sale
|
Direct |
2,500
-12.39%
|
$110,000
$44.51 P/Share
|
|
Aug 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$283,360
$46.03 P/Share
|
|
Aug 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Aug 05
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.13%
|
$550,128
$48.37 P/Share
|
|
Aug 05
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.96%
|
$11,461
$1.64 P/Share
|
|
Aug 03
2021
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
11,461
-4.13%
|
$550,128
$48.26 P/Share
|
|
Aug 03
2021
|
Michael Rice |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+3.96%
|
$11,461
$1.64 P/Share
|
|
Jul 29
2021
|
Michael Rice |
SELL
Bona fide gift
|
Direct |
3,000
-1.11%
|
-
|
|
Jul 26
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
4,919
-6.88%
|
$226,274
$46.13 P/Share
|
|
Jul 26
2021
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
16,333
-18.33%
|
$734,985
$45.24 P/Share
|
|
Jul 26
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,333
+15.49%
|
$16,333
$1.64 P/Share
|
|
Jul 21
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,854
-4.05%
|
$398,430
$45.61 P/Share
|
|
Jul 21
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,854
+3.9%
|
$8,854
$1.64 P/Share
|
|
Jul 20
2021
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,059
-5.07%
|
$47,655
$45.1 P/Share
|
|
Jul 20
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
2,539
-6.53%
|
$114,255
$45.1 P/Share
|
|
Jul 19
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-4.55%
|
$430,000
$43.85 P/Share
|
|
Jul 19
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.36%
|
$10,000
$1.64 P/Share
|
|
Jul 16
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,160
-7.23%
|
$271,040
$44.04 P/Share
|
|
Jul 16
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,160
+6.74%
|
$6,160
$1.64 P/Share
|
|
Jul 15
2021
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,165
-7.23%
|
$258,930
$42.74 P/Share
|
|
Jul 15
2021
|
Todd Berard Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,165
+6.75%
|
$6,165
$1.64 P/Share
|
|
Jul 15
2021
|
Andrew G Hinson Director |
SELL
Open market or private sale
|
Direct |
2,500
-11.03%
|
$110,000
$44.44 P/Share
|
|
Jul 12
2021
|
Raymond W Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+15.26%
|
-
|
|
Jul 12
2021
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+25.81%
|
-
|